As of Jul 20
| -0.03 / -0.04%|
The 1 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 92.00, with a high estimate of 92.00 and a low estimate of 92.00. The median estimate represents a +19.54% increase from the last price of 76.96.
The current consensus among 4 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.